James Investment Research’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-650
| Closed | -$19K | – | 885 |
|
|
2017
Q3 | $19K | Hold |
650
| – | – | ﹤0.01% | 700 |
|
|
2017
Q2 | $17K | Hold |
650
| – | – | ﹤0.01% | 675 |
|
|
2017
Q1 | $15K | Hold |
650
| – | – | ﹤0.01% | 612 |
|
|
2016
Q4 | $16K | Sell |
650
-325
| -33% | -$8.21K | ﹤0.01% | 482 |
|
|
2016
Q3 | $27K | Hold |
975
| – | – | ﹤0.01% | 448 |
|
|
2016
Q2 | $24K | Sell |
975
-245,400
| -100% | -$6.09M | ﹤0.01% | 407 |
|
|
2016
Q1 | $5.45M | Buy |
246,375
+22,540
| +10% | +$600K | 0.13% | 137 |
|
|
2015
Q4 | $7.83M | Sell |
223,835
-76,452
| -25% | -$2.39M | 0.19% | 122 |
|
|
2015
Q3 | $8.55M | Buy |
300,287
+207,787
| +225% | +$6.98M | 0.23% | 110 |
|
|
2015
Q2 | $3.08M | Buy |
92,500
+40,300
| +77% | +$1.24M | 0.07% | 165 |
|
|
2015
Q1 | $1.47M | Sell |
52,200
-16,037
| -24% | -$399K | 0.03% | 217 |
|
|
2014
Q4 | $1.41M | Sell |
68,237
-7,778
| -10% | -$185K | 0.04% | 208 |
|
|
2014
Q3 | $1.86M | Buy |
76,015
+36,375
| +92% | +$965K | 0.06% | 181 |
|
|
2014
Q2 | $1.13M | Buy |
+39,640
| New | +$1.1M | 0.04% | 206 |
|
James Investment Research's PMC Position: Q4 2017 in Review
James Investment Research sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 650 shares — an estimated $19K sold.
James Investment Research first reported a position in PMC in Q2 2014 and held it in 14 quarters. The position peaked at $8.55M in Q3 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- James Investment Research reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- James Investment Research sold 650 PharMerica Corporation shares in Q4 2017, an estimated $19K.
- James Investment Research first reported a position in PharMerica Corporation in Q2 2014 and held it in 14 quarters.
- James Investment Research's PharMerica Corporation position peaked at $8.55M in Q3 2015.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on James Investment Research's 13F filing for Q4 2017, filed 23 Jan 2018.